Global Asthma Spacers Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Asthma Spacers Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Asthma spacers are a metered inhaler (MDI) for adding a device that facilitates the administration of aerosolized medication from one. It adds space in the form of a tube or chamber between the mouth and the drug tank. Most spacers have a one-way valve that allows people to inhale the drug during normal inhalation and exhalation. These are often referred to as valved holding chambers (VHC).

Market Overview:

The latest research study on the global Asthma Spacers market finds that the global Asthma Spacers market reached a value of USD 853.21 million in 2022. It’s expected that the market will achieve USD 1052.97 million by 2028, exhibiting a CAGR of 3.57% during the forecast period.

Limitations

Asthma patients lack sufficient knowledge of Asthma Spacers, which has led to some patients refusing treatment, thus hindering the development of the industry.
Although using spacers can make the inhaler easier to use, once the drug is released, the patient must focus on breathing. Uninhaled medication will fall on the bottom of the spacers. Since some medications and moisture from the breath can remain in the pad, the device needs to be cleaned frequently. This makes the use of spacer’s time consuming and may become difficult when used to young children, patients with special needs, and the elderly, which will further affect adoption and market growth.
In addition, the high-quality standards established by top companies have hindered the development of small businesses. Some companies make low-cost products, increasing the possibility of counterfeit products entering the market. The use of inferior materials in the production of these products can affect brand image and affect the market.

Market participants increase investment in research and development

Market participants are very active in providing valuable products that meet customer needs. Industry participants have invested heavily in research and development activities to develop highly advanced products. Appropriate advances in product supply have driven increased demand for asthma spacers for respiratory therapy.

Government support

Various government initiatives and activities undertaken by global organizations have further increased access to healthcare in global markets. Increased awareness of asthma treatment, increased drug market access, and increased personal purchasing power are the key factors driving the asthma spacers market. As the global prevalence of respiratory diseases increases, the government has increased various medical supports, which provides an important opportunity for the development of the asthma spacers industry.

Region Overview:

North America dominated the Asthma Spacers market in 2022, with a market share of 33.39%.

Company Overview:

Philips is one of the major players operating in the Asthma Spacers market, holding a share of 8.87% in 2023.

Philips

Koninklijke Philips NV is a health technology company focused on improving people's health across the health continuum from healthy living and prevention, to diagnosis, treatment, and home care. The Company offers products and services in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Allergan

Allergan PLC manufactures specialty pharmaceuticals. The Company develops, manufactures, and distributes generic, brand, and over-the-counter products. Allergan offers its pharmaceutical drugs around the world.

Segmentation Overview:

Among different product types, Aerochamber segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Retail Pharmacy segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Asthma Spacers market covered in Chapter 3:

Allergan
GlaxoSmithKline
InspiRX Inc
Cipla Limited
Philips
Lupin Limited
Trudell Medical
Teleflex Incorporated
Pari GmbH
Clement Clarke

In Chapter 4 and Chapter 14.2, on the basis of types, the Asthma Spacers market from 2018 to 2029 is primarily split into:

Aerochamber
Optichamber
Volumatic
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Asthma Spacers market from 2018 to 2029 covers:

Retail Pharmacy
Hospital Pharmacy
Online Channel

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)